121 related articles for article (PubMed ID: 9145378)
1. In vivo evaluation of zidovudine (AZT)-loaded ethylcellulose microspheres after oral administration in beagle dogs.
Abu-Izza K; Tambrallo L; Lu DR
J Pharm Sci; 1997 May; 86(5):554-9. PubMed ID: 9145378
[TBL] [Abstract][Full Text] [Related]
2. Effect of gastrointestinal protein adsorption on the in vitro release of AZT from ethylcellulose microspheres.
Abu-Izza KA; Lu DR
Pharm Dev Technol; 1998 Nov; 3(4):495-501. PubMed ID: 9834952
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.
Medeiros DC; Mazon-Cardoso T; Lemos-Senna E; Poli A
Pharmazie; 2009 Oct; 64(10):648-52. PubMed ID: 19947166
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gastroretentive microspheres and sustained-release preparations using theophylline pharmacokinetics.
Miyazaki Y; Yakou S; Takayama K
J Pharm Pharmacol; 2008 Jun; 60(6):693-8. PubMed ID: 18498704
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of sustained release AZT-loaded microspheres: optimization of the release characteristics using response surface methodology.
Abu-Izza KA; Garcia-Contreras L; Lu DR
J Pharm Sci; 1996 Feb; 85(2):144-9. PubMed ID: 8683438
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine).
Li W; Chang Y; Zhan P; Zhang N; Liu X; Pannecouque C; De Clercq E
ChemMedChem; 2010 Nov; 5(11):1893-8. PubMed ID: 20936623
[TBL] [Abstract][Full Text] [Related]
7. Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats.
Kumar P; Lakshmi YS; C B; Golla K; Kondapi AK
PLoS One; 2015; 10(10):e0140399. PubMed ID: 26461917
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
Narishetty ST; Panchagnula R
Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
[TBL] [Abstract][Full Text] [Related]
9. Poly(HEMA-Zidovudine) conjugate: a macromolecular pro-drug for improvement in the biopharmaceutical properties of the drug.
Neeraj A; Chandrasekar MJ; Sara UV; Rohini A
Drug Deliv; 2011 May; 18(4):272-80. PubMed ID: 21110710
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of zidovudine following intravenous bolus administration of a novel niosome preparation devoid of cholesterol.
Gopinath D; Ravi D; Karwa R; Rao BR; Shashank A; Rambhau D
Arzneimittelforschung; 2001 Nov; 51(11):924-30. PubMed ID: 11765596
[TBL] [Abstract][Full Text] [Related]
11. Zidovudine serum, cerebrospinal fluid, and brain concentrations following chronic administration of a new zidovudine formulation via an implantable pump in dogs [corrected].
Gallo JM; Sanzgiri Y; Howerth EW; Finco TS; Wilson J; Johnston J; Tackett R; Budsberg SC
J Pharm Sci; 1992 Jan; 81(1):11-5. PubMed ID: 1619563
[TBL] [Abstract][Full Text] [Related]
12. A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice.
Huang Y; Wei Y; Yang H; Pi C; Liu H; Ye Y; Zhao L
Drug Des Devel Ther; 2016; 10():997-1008. PubMed ID: 27042001
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evaluation of drug interactions with zidovudine. I: Probenecid and zidovudine in monkeys.
Qian MX; Finco TS; Mehta M; Viswanathan CT; Gallo JM
J Pharm Sci; 1991 Nov; 80(11):1007-11. PubMed ID: 1815049
[TBL] [Abstract][Full Text] [Related]
14. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine.
Quevedo MA; Briñón MC
Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583
[TBL] [Abstract][Full Text] [Related]
16. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
[TBL] [Abstract][Full Text] [Related]
17. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
18. Technology to obtain sustained release characteristics of drugs after delivered to the colon.
Hu Z; Kimura G; Ito Y; Mawatari S; Shimokawa T; Yoshikawa H; Yoshikawa Y; Takada K
J Drug Target; 1999; 6(6):439-48. PubMed ID: 10937289
[TBL] [Abstract][Full Text] [Related]
19. Development of novel prasugrel base microsphere-loaded tablet with enhanced stability: Physicochemical characterization and in vivo evaluation in beagle dogs.
Kim KS; Kim JC; Jin SG; Kim DW; Kim DS; Yong CS; Kim JO; Youn YS; Oh KT; Woo JS; Choi HG
Colloids Surf B Biointerfaces; 2016 Oct; 146():754-61. PubMed ID: 27451362
[TBL] [Abstract][Full Text] [Related]
20. Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs.
Shin S; Kim TH; Jeong SW; Chung SE; Lee DY; Kim DH; Shin BS
PLoS One; 2019; 14(5):e0216875. PubMed ID: 31091273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
